August 13, 2024 - August 16, 2024

Broach Lifecare Hospital IPO Review & Recommendations

Dilip Davda recommend to "Avoid" the IPO.

Broach Lifecare Hospital IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	0	0	1	0
%	0.00	0.00	0.00	100.00	0.00

Broach Lifecare Hospital IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Avoid

Broach Lifecare Hospital IPO Review by Dilip Davda (Avoid)

[Dilip Davda] The company is in the healthcare segment running multi-speciality hospitals in and around Bharuch. It posted mix bag of financial performance as a proprietorship concern and as a corporate entity. Based on FY24 earnings, relatively the issue is aggressively priced. Small equity base post-IPO indicates longer gestation period for migration. There is no harm in skipping this relatively pricey issue. Read detail review...

Broach Lifecare Hospital IPO Peer Comparison

Broach Lifecare Hospital Limited peer comparison with similar listed entities. (As on March 31, 2024)

Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio	Financial statements
Broach Lifecare Hospital Limited	1.92	1.92	12.26	13.02	12.75	2.04
Family Care Hospitals Ltd	2.32	2.32	10.81	3.37	21.50	0.72	Standalone
Kmc Speciality Hospitals (india) Ltd.	1.86	1.86	44.26	8.80	21.16	1.86	Standalone
Global Longlife Hospital And Research Ltd	-2.08	-2.08	2.47	-14.42	-8.44	12.15	Standalone

Source: All the financial information for listed industry peers mentioned above is on a standalone basis) and is sourced from the filings made with stock exchanges, available on www.bseindia.com and www.nseindia.com for the Financial Year ending March 31, 2024.

Notes:

Considering the nature and size of the company's business, the peers are not strictly comparable. However, the above company is included for broad comparison.
The figures for Broach Lifecare Hospital Limited are based on the restated financial statements for the year ended March 31, 2024.
The figures for the peer group are for the year ended March 31, 2024, and are based on their respective financial statements filed with BSE Ltd.
NAV is computed as the closing net worth divided by the closing outstanding number of equity shares. Net worth has been computed as the aggregate of share capital, reserves, and surplus (excluding Revaluation Reserves) and as attributable to the company's owners.
P/E Ratio for the peer has been computed based on the closing market price of respective Equity Shares as of August 5, 2024, sourced from the website of the Stock Exchange as divided by the Basic/diluted EPS as applicable.
RoNW is computed as net profit after tax (excluding comprehensive income), as attributable to the company's owners, divided by closing net worth. Net worth has been computed as the aggregate of share capital, reserves, and surplus (excluding Revaluation Reserves), as attributable to the company's owners.

Broach Lifecare Hospital IPO Review by Members

Broach Lifecare Hospital IPO Reviews, analysis and views by popular members. Read Broach Lifecare Hospital Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Broach Lifecare Hospital IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%

Member	Review
No recommendation found. Be the first to post the recommendation.

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Comments

Add a public comment...